|
|
|
|
| LEADER |
00992nam a2200325Ia 4500 |
| 001 |
10-1016-j-jhepr-2021-100382 |
| 008 |
220420s2022 CNT 000 0 und d |
| 020 |
|
|
|a 25895559 (ISSN)
|
| 245 |
1 |
0 |
|a Strategies for a two-step liver fibrosis assessment in clinical practice
|
| 260 |
|
0 |
|b Elsevier B.V.
|c 2022
|
| 856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1016/j.jhepr.2021.100382
|
| 650 |
0 |
4 |
|a clinical practice
|
| 650 |
0 |
4 |
|a digestive system disease assessment
|
| 650 |
0 |
4 |
|a FIB-4
|
| 650 |
0 |
4 |
|a Fibrosis 4 Score
|
| 650 |
0 |
4 |
|a glycemic control
|
| 650 |
0 |
4 |
|a human
|
| 650 |
0 |
4 |
|a Letter
|
| 650 |
0 |
4 |
|a liver fibrosis
|
| 650 |
0 |
4 |
|a medical society
|
| 650 |
0 |
4 |
|a NAFLD
|
| 650 |
0 |
4 |
|a non insulin dependent diabetes mellitus
|
| 650 |
0 |
4 |
|a nonalcoholic fatty liver
|
| 650 |
0 |
4 |
|a patient care
|
| 650 |
0 |
4 |
|a patient navigator
|
| 650 |
0 |
4 |
|a T2DM
|
| 650 |
0 |
4 |
|a transient elastography
|
| 700 |
1 |
0 |
|a Lai, M.
|e author
|
| 700 |
1 |
0 |
|a Vieira Barbosa, J.
|e author
|
| 773 |
|
|
|t JHEP Reports
|
